COST-EFFECTIVENESS OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE (PF-ILD) IN THE NETHERLANDS

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S716-S717
Number of pages2
JournalValue in Health
Volume23
DOIs
Publication statusPublished - 1-Dec-2020

Cite this